Abstract:Obesity is a leading preventable cause of death worldwide with increasing prevalence in adults and children. It is one of the most serious public health problems of the twenty-first century. Visfatin, known as pre-B-cell colony-enhancing factor (PBEF) and nicotinamide phosphoribosyltransferase (Nampt), is regarded as a novel adipokine and may have a function as a direct proinflammatory mediator of obesity-related vascular disorders with a potential role in plaque destabilisation. Visfatin/PBEF/Nampt is preferentially expressed by visceral adipose tissue compared with subcutaneous fat. AMP-activated protein kinase (AMPK) is a key molecular player in energy homoeostasis at both cellular and whole-body levels. AMPK has been shown to have a role in the physiological regulation of fatty acid and glucose metabolism, and in the regulation of appetite and body weight. Therefore, AMPK is considered a major player in the development of obesity. The model of diet-induced obesity (DIO) in rats has many features in common with human obesity and can serve as a useful model to study the pathogenesis and treatment of obesity. In Wistar rats, half the rats become hyperphagic and develop DIO, whereas the rest are diet-resistant (DR) when the rats are fed with a high fat (44% fat) diet. The present study investigated the relationship between visfatin and AMPK in DIO and DIO-restricted rats. Male Sprague–Dawley rats (n 110) at 3 weeks of age were randomly assigned into groups. Ten rats were fed rat chow during the study as the control and 100 rats were fed both rat chow plus high fat diet (HFD, 5.58 kcal/g (23.34672 kJ/g) with 66.5% as fat) ad libitum for 14 weeks. At the end of this period, forty-four rats developed DIO which was assessed by the Lee obesity index. The Lee obesity index was calculated by dividing the cube root of body weight (g) by body length (cm) · 1000. The DIO rat’s Lee obesity index was more than the average Lee obesity index plus 2 SD of the chow-fed control rats. At week 15, ten chow-fed control rats were kept on the rat chow, eleven DIO rats were kept on the rat chow plus HFD ad libitum and the other eleven DIO rats that were designated as DIO-restricted, were restricted on the intake of the rat chow plus HFD for 5 weeks. Other rats were used in other studies (data not presented). Plasma visfatin concentration was significantly lower in both DIOrestricted and chow-fed control rats than DIO rats and was 69 and 70% of DIO rats, respectively. DIO-restricted rats had significantly lower visfatin expression in the visceral adipose tissue than DIO rats, however, they had significantly higher visfatin expression than chow-fed control rats (Fig. 1). Moreover, the activity of AMPK in the visceral adipose tissue tended to be higher in both DIO-restricted and chow-fed control rats than DIO rats (Fig. 1). These results indicate that visfatin and AMPK may play important roles in the development of obesity. The lowered visfatin expression and elevated AMPK activity in visceral adipose tissue in DIO-restricted rats may stimulate fatty acid oxidation, and we hypothesise that inactive visfatin and activate AMPK may be of therapeutic targets in obesity.

Intraventricular Injection of LKB1 Inhibits the Formation of Diet-Induced Obesity in Rats by Activating the AMPK-POMC Neurons-Sympathetic Nervous System Axis

Peripheral Neuropathy and Hindlimb Paralysis in a Mouse Model of Adipocyte-Specific Knockout of Lkb1.

Diet-induced Obese Rats Exhibit Impaired LKB1–AMPK Signaling in Hypothalamus and Adipose Tissue

Loss of Lkb1 in CD11c+ myeloid cells protects mice from diet-induced obesity while enhancing glucose intolerance and IL-17/IFN-γ imbalance

Brain apolipoprotein E: an important regulator of food intake in rats

Dendritic cell–intrinsic LKB1-AMPK/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity

Lkb1 Controls Brown Adipose Tissue Growth and Thermogenesis by Regulating the Intracellular Localization of CRTC3.

Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver

A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes

Visfatin As a Novel Adipokine in Relation to AMP-activated Protein Kinase in Obesity and Weight Loss

LKB1 signalling in dendritic cells controls whole-body metabolic homeostasis by limiting T helper 17 priming

Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner

Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance

Adipocyte-specific DKO of Lkb1 and Mtor Protects Mice Against HFD-induced Obesity, but Results in Insulin Resistance.

Leptin limits hepatic lipid accumulation and inflammation via vagal activation of the JAK2-STAT3/AMPK pathway

Lactobacillus amylovorus KU4 ameliorates diet-induced obesity in mice by promoting adipose browning through PPARγ signaling

SF1-Specific AMPKα1 Deletion Protects Against Diet-Induced Obesity

Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in mice

AKAP1 Deficiency Attenuates Diet‐Induced Obesity and Insulin Resistance by Promoting Fatty Acid Oxidation and Thermogenesis in Brown Adipocytes

Disruption of the AMPK-TBC 1 D 1 Nexus Increases Lipogenic Gene Expression and Causes Obesity in Mice Via Promoting IGF 1 Secretion

Identification of a GABAergic Neural Circuit Governing Leptin Signaling Deficiency-Induced Obesity